Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients
| Press release
News & Events
Artios Pharma Expands US Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer
| Press release
Artios shaking up the Biotech scene in Cambridge Top 15 !
| Media coverage
Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
| Press release
We are excited to announce Artios has moved to brand new labs and offices on the Babraham Research Campus.
| Announcement
